Cartistem-adipo

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCartistem-adipo
Drug Alias Namestem cell therapy (Medipost)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Adipose stem cell therapy
Mechanisms of ActionStem cells modulators
TargetsUpdating
Therapy Area/IndicationsArthritis, RheumatoidJoint Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedipost Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedipost Co Ltd
Active IndicationsN/A
Inactive IndicationsArthritis, RheumatoidJoint Diseases

Other Information

ATC CodeN/A
Related LinksN/A